Cargando…

Putative Secondary Structure at 5’UTR as a Potential Antiviral Target against SARS-CoV-2

SARS-CoV-2 is an enveloped positive-sense single-stranded RNA coronavirus that causes COVID-19, of which the current outbreak has resulted in a high number of cases and fatalities throughout the world, even vaccine doses are being administered. The aim of this work was to scan the SARS-CoV-2 genome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Moran, Emilio, Hernández, Marta, Abad, David, Eiros, José M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Quimioterapia 2021
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972695/ https://www.ncbi.nlm.nih.gov/pubmed/34905913 http://dx.doi.org/10.37201/req/153.2021

Ejemplares similares

Secondary structure of the SARS-CoV-2 5’-UTR
por: Miao, Zhichao, et al.
Publicado: (2020)

Are Animals a Neglected Transmission Route of SARS-CoV-2?
por: Hernández, Marta, et al.
Publicado: (2020)

Antiviral drugs against SARS-CoV-2
por: Aiello, Tommaso Francesco, et al.
Publicado: (2022)

The evolution of SARS-CoV-2 variants and their clinical and healthcare implications()
por: Eiros, J.M., et al.
Publicado: (2022)

Extended ensemble simulations of a SARS-CoV-2 nsp1–5’-UTR complex
por: Sakuraba, Shun, et al.
Publicado: (2022)

Antiviral Effect of Budesonide against SARS-CoV-2
por: Heinen, Natalie, et al.
Publicado: (2021)

Theory and reality of antivirals against SARS-CoV-2
por: Zhao, Bo, et al.
Publicado: (2021)

Antiviral Efficacy of Pralatrexate against SARS-CoV-2
por: Bae, Joon-Yong, et al.
Publicado: (2021)

Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

The heart and SARS-CoV-2
por: González-Calle, David, et al.
Publicado: (2022)

In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2
por: Villalobos-Sánchez, Erendira, et al.
Publicado: (2023)

Potential use of noncoding RNAs and innovative therapeutic strategies to target the 5’UTR of SARS-CoV-2
por: Baldassarre, Antonella, et al.
Publicado: (2020)

3′-UTR of the SARS-CoV-2 genome as a possible source of piRNAs
por: Hernández-Huerta, María Teresa, et al.
Publicado: (2022)

Potential Antiviral Options against SARS-CoV-2 Infection
por: Ianevski, Aleksandr, et al.
Publicado: (2020)

In Vitro Antiviral Activity of Doxycycline against SARS-CoV-2
por: Gendrot, Mathieu, et al.
Publicado: (2020)

Lack of antiviral activity of darunavir against SARS-CoV-2
por: De Meyer, Sandra, et al.
Publicado: (2020)

First-generation oral antivirals against SARS-CoV-2
por: Sendi, Parham, et al.
Publicado: (2022)

Potential antiviral peptides against the nucleoprotein of SARS-CoV-2
por: Mahdi, Iktedar, et al.
Publicado: (2022)

Potential antiviral effects of pantethine against SARS-CoV-2
por: Abou-Hamdan, M., et al.
Publicado: (2023)

5-Aminolevulinic acid antiviral efficacy against SARS-CoV-2 omicron variant in vitro
por: Ngwe Tun, Mya Myat, et al.
Publicado: (2022)

Corazón y SARS-CoV-2
por: González-Calle, David, et al.
Publicado: (2022)

The SARS-CoV-2 UTR's Intrudes Host RBP's and Modulates Cellular Splicing
por: Singh, Anjali, et al.
Publicado: (2023)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

La evolución en variantes del SARS-CoV-2 y su repercusión clínica y sanitaria
por: Eiros, J.M., et al.
Publicado: (2022)

Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2
por: Carrouel, F., et al.
Publicado: (2020)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

An in vitro antiviral activity of iodine complexes against SARS-CoV-2
por: Altaf, Imran, et al.
Publicado: (2021)

Boron enhances the antiviral activity of the curcumin against SARS-CoV-2
por: Scorei, Ion Romulus, et al.
Publicado: (2020)

Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2
por: Tonk, Miray, et al.
Publicado: (2021)

In silico evidence of beauvericin antiviral activity against SARS-CoV-2
por: Al Khoury, Charbel, et al.
Publicado: (2022)

Antiviral Activity of Zinc Oxide Nanoparticles against SARS-CoV-2
por: Wolfgruber, Stella, et al.
Publicado: (2023)

Antiviral activity of salt-coated materials against SARS-CoV-2
por: Coleman, Christopher M., et al.
Publicado: (2023)

Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
por: Grosche, Victória Riquena, et al.
Publicado: (2023)

5-Hydroxymethyltubercidin exhibits potent antiviral activity against flaviviruses and coronaviruses, including SARS-CoV-2
por: Uemura, Kentaro, et al.
Publicado: (2021)

Statistical analysis supports UTR (untranslated region) deletion theory in SARS-CoV-2
por: Xu, Zhaobin, et al.
Publicado: (2022)

Targeting stem-loop 1 of the SARS-CoV-2 5′ UTR to suppress viral translation and Nsp1 evasion
por: Vora, Setu M., et al.
Publicado: (2022)

Supramolecular Cylinders Target Bulge Structures in the 5′ UTR of the RNA Genome of SARS‐CoV‐2 and Inhibit Viral Replication
por: Melidis, Lazaros, et al.
Publicado: (2021)

Optimization of 5′UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells
por: Chen, Shih-Cheng, et al.
Publicado: (2023)

Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV
por: Scroggs, Stacey L. P., et al.
Publicado: (2020)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rdbp0d57rrl6jg6d757pqdkcc